3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
8
Neoplasm Metastasis
5
Breast Neoplasms
5
Neoplasms
3
Recurrence
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Obesity
2
Multiple Myeloma
2
Metabolic Diseases
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Insulin Resistance
2
Infertility
2
Glioblastoma
2
Carcinoma, Ovarian Epithelial
2
Brain Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Thrombocytopenia
1
TP53 Y220C Mutation
1
Splenomegaly
1
Solid Tumor, Adult
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Mycosis Fungoides
1
Mouth Neoplasms
1
Interventions
Metformin
1
Fish Oils
1
Docosahexaenoic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Lipid Metabolism Disorders
×
Metformin
×
Clear all
NCT04116203
2025-02-28
PCOS
University of Alberta
Phase 1
Completed
52 enrolled